Latest Trustworthy News from Dr. Mercola - delivered straight to your inbox!
Get 25% Off Sitewide on Cyber Monday Sale Get 25% Off Sitewide on Cyber Monday Sale

Pfizer's New Game Plan to Promote Celebrex

  • February 23, 2005

Shortly after Merck's Vioxx was pulled from the consumer market in this country, rival Pifzer announced a bold, but ultimately failed, move to bolster Celebrex's marketshare: A study to determine if the COX-2 inhibitor could prevent heart attacks. Two months later, high doses of Celebrex were found to cause the same problem as Vioxx -- An increased risk of heart attacks for patients taking high doses. On the heels of last week's FDA meeting that argued the merits of COX-2 inhibitors...
Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports